Last reviewed · How we verify
NCT06786273
Time Course of Endometrium's Gene Expression Profiles Using Endometrial Tissue and Blood Samples
EARLY_PHASE1 trial testing Small RNA sequencing in Fertility in 62 participants. Completed in 6 February 2024.
6 February 2024
Quick facts
| Lead sponsor | Inti Labs |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 62 |
| Start date | 31 March 2023 |
| Primary completion | 6 February 2024 |
| Estimated completion | 6 February 2024 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Small RNA sequencing
Conditions studied
- Fertility — all drugs for Fertility →
Sponsor
Inti Labs
Who can join
Adults 25 to 38, female only, with Fertility. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to investigate whether the expression levels of microRNA (miRNA) in endometrial tissue and blood samples at various time points after ovulation can serve as biomarkers for assessing endometrial receptivity.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06786273
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Small RNA sequencing
Trials testing the same drug.
- NCT07226154 — Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer · recruiting
- NCT07225452 — An Exosomal miRNA-based Liquid Biopsy for ICC Detection · completed
Other recruiting trials for Fertility
Currently open trials in the same condition.
- NCT07319429 — Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification · Phase 2, PHASE3 · recruiting
- NCT07248046 — Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study) · recruiting
- NCT07514377 — JiGenerations Health Cohort Study：Parental Exposure and Intergenerational Health in China · active not recruiting
- NCT06862440 — Kegg Fertility Study · recruiting
- NCT06705712 — Physical Activity, Fertility, and Spontaneous Abortion in Danish Couples Trying to Conceive · NA · recruiting
Other Inti Labs trials
Trials by the same sponsor.
- NCT06839495 — To Investigate the Relationship Between the Viscoelastic Properties of the Zona Pellucida of Human Oocyte and the Blasto · recruiting
- NCT06544837 — Trial to Evaluate the Clinical Utility of Non-invasive Endometrial Receptivity Test (Ora) in Patients With Implantation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06786273 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Inti Labs
- Last refreshed: 22 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06786273.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing